Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients - Wikidata - wikimedia - TriplyDB

Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients

Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients

http://www.wikidata.org/entity/Q36622390

about

The detection, treatment, and biology of epithelial ovarian cancer The mechanisms by which polyamines accelerate tumor spread.TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.Epigenetic biomarkers of T-cells in human glioma.Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.Covert operations: cancer's many subversive tactics in overcoming host defenses.Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer Extracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Regulation of T cell receptor CD3zeta chain expression by L-arginine.Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.JAK3, STAT3 and CD3-zeta signaling proteins status in regard to the lymphocytes function in patients with ovarian cancer.

P2860

Q21198791-84A86038-BC2A-4D18-9B7B-C2F6ECA60B5D Q35505118-8C5A84E4-332A-40D9-B503-52CD3AE6F4C0 Q35877202-A7A29FD1-D741-4E3E-AE40-30E2892A2DB0 Q36484129-F5A2E26A-0CCE-4012-BA1A-BD423D9133DC Q36542190-FC678444-C9D7-436D-948D-2E9799417042 Q36648706-B34ED948-942B-47D5-913E-484EF3F76D54 Q37026063-E4F7CF37-24DD-4C78-8301-D8A577D5624A Q37355075-CFB77544-D4F1-4498-B11D-24087CF13B8D Q37891886-DA3E3864-6EA7-46C7-81A0-B32046FA807D Q38281731-1F54EF48-83CC-483C-8D69-AB8E7DE0E7B9 Q38817649-824E42A7-0CC3-4AEE-90EA-B08642DC9494 Q43957769-550E085E-57F1-4D2C-9DF6-85BEBA99E59B Q44638209-05B93409-59B3-4D3B-9F11-9172E15ED549 Q50997188-3F45FB01-26F6-4293-870F-55C3C0523B9D Q54538366-6EB64F01-EA32-4601-AA58-B3AC45E95572

P2860

Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients

http://www.wikidata.org/entity/Q36622390

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@ast

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@en

type

label

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@ast

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@en

prefLabel

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@ast

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@en

P1433

Q36622390-3BF693C4-856E-407E-A9EE-A1E37ABD70A6

P1476

Q36622390-511287E9-4786-4D7B-A365-52001562DAB6

P2093

Q36622390-0FB2DE10-7B09-4114-BBF4-1101EE0C0AFC

Q36622390-1B4F1237-B264-4ADD-A636-159037C29754

Q36622390-1F0A0681-F2AA-44AC-B2E6-DC23221959B4

Q36622390-3C7A841F-4DB3-4CA3-944C-82673231D5F3

Q36622390-5BE37C67-1A84-4AA5-AB08-DAE080344944

P2860

Q36622390-149CE6FB-AA11-4B49-8AC9-AB1A1DBF9921

Q36622390-2285DBCC-2187-4478-BBAE-988B449FB829

Q36622390-26CB46F1-BB46-4874-9ADC-BD690A9CD356

Q36622390-2A7DB8FE-3554-4AB4-AFB3-824631006B3B

Q36622390-346EC22B-E14E-4A78-ACE9-B4E0BCD71349

Q36622390-36CF75DC-ADB7-48ED-9DB8-A06CBB50DA64

Q36622390-3C7FD527-D618-4336-AA9F-7C9441B14778

Q36622390-40E0EB06-17D5-4441-992B-3F49AB135988

Q36622390-48CA57EA-49D0-41FB-B42F-2A6ABA09C91B

Q36622390-51483510-EB21-437B-B8EC-FEC523E657A4

P2888

Q36622390-ED61DF99-C584-4004-BDC6-ED0C822667B3

P304

Q36622390-7465CBB4-09A9-4BB3-B04D-B037BC1DFD43

P31

Q36622390-FDB91683-2CA1-4B8C-BFE0-3BCE86F8CA55

P356

Q36622390-4B707AF6-5208-45AA-806E-9D420E1AC6D3

P407

Q36622390-F11AE0F5-534D-4BDF-8B38-4DB6EB89965D

P433

Q36622390-039A29C1-01FE-49AA-82D7-11041E7BDC77

P478

Q36622390-1CFF970A-E82F-4029-A77A-B2CD0FDD7AAA

P577

Q36622390-D24D99AE-8DBA-4266-A87E-BBF63BB2ADEB

P5875

Q36622390-591B7319-4F4A-4A97-A1AB-DB874CED5CC5

P6179

Q36622390-9F6E679F-78C0-4407-BBED-8833C0920A7D

P698

Q36622390-F5E5E7E2-BE28-4CEC-8296-113B0F00D71F

P921

Q36622390-6071512A-3B89-4E84-B144-2B604FEFED2F

P932

Q36622390-BC5B798F-7441-40A1-8B5A-4FDD2663D99D

P356

P1433

British Journal of Cancer

P1476

Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients

@en

P2093

Bender DP

http://www.w3.org/2001/XMLSchema#string

Gerçel-Taylor C

http://www.w3.org/2001/XMLSchema#string

Stanson J

http://www.w3.org/2001/XMLSchema#string

Taylor DD

http://www.w3.org/2001/XMLSchema#string

Whiteside TL

http://www.w3.org/2001/XMLSchema#string

P2860

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain.

Partially phosphorylated T cell receptor zeta molecules can inhibit T cell activation.

Role of the multiple T cell receptor (TCR)-zeta chain signaling motifs in selection of the T cell repertoire.

Expression of CD3-zeta on T-cells in primary cervical carcinoma and in metastasis-positive and -negative pelvic lymph nodes

Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain.

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.

Immunologic approaches to the management of ovarian carcinoma.

Serial immune function testing to predict clinical disease relapse in patients with solid tumors.

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

P2888

P304

1624-1629

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1847

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2001-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11938988

http://www.w3.org/2001/XMLSchema#string

P6179

1038794005

http://www.w3.org/2001/XMLSchema#string

P698

11401315

http://www.w3.org/2001/XMLSchema#string

P921

P932

2363678

http://www.w3.org/2001/XMLSchema#string